149 related articles for article (PubMed ID: 16453385)
1. Pathogen-specific TLR signaling in mucosa: mutual contribution of microbial TLR agonists and virulence factors.
Sirard JC; Bayardo M; Didierlaurent A
Eur J Immunol; 2006 Feb; 36(2):260-3. PubMed ID: 16453385
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.
Fischer H; Yamamoto M; Akira S; Beutler B; Svanborg C
Eur J Immunol; 2006 Feb; 36(2):267-77. PubMed ID: 16385628
[TBL] [Abstract][Full Text] [Related]
3. Uropathogenic Escherichia coli as a model of host-parasite interaction.
Svanborg C; Bergsten G; Fischer H; Godaly G; Gustafsson M; Karpman D; Lundstedt AC; Ragnarsdottir B; Svensson M; Wullt B
Curr Opin Microbiol; 2006 Feb; 9(1):33-9. PubMed ID: 16406777
[TBL] [Abstract][Full Text] [Related]
4. TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections.
Ragnarsdóttir B; Fischer H; Godaly G; Grönberg-Hernandez J; Gustafsson M; Karpman D; Lundstedt AC; Lutay N; Rämisch S; Svensson ML; Wullt B; Yadav M; Svanborg C
Eur J Clin Invest; 2008 Oct; 38 Suppl 2():12-20. PubMed ID: 18826477
[TBL] [Abstract][Full Text] [Related]
5. Impact of Toll-like receptor signalling on urinary tract infection.
Scherberich JE; Hartinger A
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S9-14. PubMed ID: 17942281
[TBL] [Abstract][Full Text] [Related]
6. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins.
Cirl C; Wieser A; Yadav M; Duerr S; Schubert S; Fischer H; Stappert D; Wantia N; Rodriguez N; Wagner H; Svanborg C; Miethke T
Nat Med; 2008 Apr; 14(4):399-406. PubMed ID: 18327267
[TBL] [Abstract][Full Text] [Related]
7. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells.
Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X
Vet Res; 2008; 39(2):11. PubMed ID: 18096120
[TBL] [Abstract][Full Text] [Related]
8. Bovine TLR2 and TLR4 properly transduce signals from Staphylococcus aureus and E. coli, but S. aureus fails to both activate NF-kappaB in mammary epithelial cells and to quickly induce TNFalpha and interleukin-8 (CXCL8) expression in the udder.
Yang W; Zerbe H; Petzl W; Brunner RM; Günther J; Draing C; von Aulock S; Schuberth HJ; Seyfert HM
Mol Immunol; 2008 Mar; 45(5):1385-97. PubMed ID: 17936907
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection.
Godaly G; Bergsten G; Hang L; Fischer H; Frendéus B; Lundstedt AC; Samuelsson M; Samuelsson P; Svanborg C
J Leukoc Biol; 2001 Jun; 69(6):899-906. PubMed ID: 11404374
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors recognize uropathogenic Escherichia coli and trigger inflammation in the urinary tract.
Anders HJ; Patole PS
Nephrol Dial Transplant; 2005 Aug; 20(8):1529-32. PubMed ID: 15941847
[No Abstract] [Full Text] [Related]
11. Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4.
Fischer H; Ellström P; Ekström K; Gustafsson L; Gustafsson M; Svanborg C
Cell Microbiol; 2007 May; 9(5):1239-51. PubMed ID: 17223929
[TBL] [Abstract][Full Text] [Related]
12. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response.
Bergsten G; Samuelsson M; Wullt B; Leijonhufvud I; Fischer H; Svanborg C
J Infect Dis; 2004 May; 189(9):1734-42. PubMed ID: 15116313
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa.
Samuelsson P; Hang L; Wullt B; Irjala H; Svanborg C
Infect Immun; 2004 Jun; 72(6):3179-86. PubMed ID: 15155619
[TBL] [Abstract][Full Text] [Related]
14. A toll-like receptor that prevents infection by uropathogenic bacteria.
Zhang D; Zhang G; Hayden MS; Greenblatt MB; Bussey C; Flavell RA; Ghosh S
Science; 2004 Mar; 303(5663):1522-6. PubMed ID: 15001781
[TBL] [Abstract][Full Text] [Related]
15. Contribution of microbial-associated molecules in innate mucosal responses.
Alexopoulou L; Kontoyiannis D
Cell Mol Life Sci; 2005 Jun; 62(12):1349-58. PubMed ID: 15971110
[TBL] [Abstract][Full Text] [Related]
16. Effects of the Escherichia coli toxin cytolysin A on mucosal immunostimulation via epithelial Ca2+ signalling and Toll-like receptor 4.
Söderblom T; Oxhamre C; Wai SN; Uhlén P; Aperia A; Uhlin BE; Richter-Dahlfors A
Cell Microbiol; 2005 Jun; 7(6):779-88. PubMed ID: 15888081
[TBL] [Abstract][Full Text] [Related]
17. Bacterial modulation of mucosal innate immunity.
Kelly D; Conway S
Mol Immunol; 2005 May; 42(8):895-901. PubMed ID: 15829279
[TBL] [Abstract][Full Text] [Related]
18. Current concepts of molecular defence mechanisms operative during urinary tract infection.
Weichhart T; Haidinger M; Hörl WH; Säemann MD
Eur J Clin Invest; 2008 Oct; 38 Suppl 2():29-38. PubMed ID: 18826479
[TBL] [Abstract][Full Text] [Related]
19. Fimbriae-mediated adherence induces mucosal inflammation and bacterial clearance. Consequences for anti-adhesion therapy.
Connell H; Agace W; Hedlund M; Klemm P; Shembri M; Svanborg C
Adv Exp Med Biol; 1996; 408():73-80. PubMed ID: 8895779
[No Abstract] [Full Text] [Related]
20. Staphylococcus aureus and Escherichia coli cause deviating expression profiles of cytokines and lactoferrin messenger ribonucleic acid in mammary epithelial cells.
Griesbeck-Zilch B; Meyer HH; Kühn CH; Schwerin M; Wellnitz O
J Dairy Sci; 2008 Jun; 91(6):2215-24. PubMed ID: 18487644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
